M J Gitlin. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultBipolar Disorder/diagnosisBipolar Disorder/drug therapyCyclohexanols/administration & dosageCyclohexanols/adverse effectsDose-Response Relationship, DrugHumansMaleMonoamine Oxidase Inhibitors/administration & dosageMonoamine Oxidase Inhibitors/adverse effectsMyoclonus/chemically inducedMyoclonus/diagnosisReceptors, Serotonin/drug effectsSelegiline/administration & dosageSelegiline/adverse effectsSerotonin Uptake Inhibitors/administration & dosageSerotonin Uptake Inhibitors/adverse effectsSubstance Withdrawal Syndrome/diagnosisSyndromeVenlafaxine Hydrochloride
Substances： See more » CyclohexanolsMonoamine Oxidase InhibitorsReceptors, SerotoninSerotonin Uptake InhibitorsSelegilineVenlafaxine Hydrochloride
Year: 1997 PMID： 9004070 DOI： 10.1097/00004714-199702000-00022
Source DB: PubMed Journal: J Clin Psychopharmacol ISSN： 0271-0749 Impact factor: 3.153